PAHUX | RSLEX | PAHUX / RSLEX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 3 years | 22 years | - |
Gain YTD | 24.164 | 6.168 | 392% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.18M | 76.3B | 0% |
Annual Yield % from dividends | 0.00 | 0.65 | - |
Returns for 1 year | 25.31 | 8.66 | 292% |
Returns for 3 years | -8.00 | -8.01 | 100% |
Returns for 5 years | N/A | 16.66 | - |
Returns for 10 years | N/A | 41.75 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHSAX | 63.69 | N/A | N/A |
BlackRock Health Sciences Opps Inv A | |||
FCGYX | 19.70 | -0.07 | -0.35% |
NYLI PineStone Global Equity Class C | |||
BRIUX | 17.17 | -0.07 | -0.40% |
Baron Real Estate Income R6 | |||
BCSCX | 7.88 | -0.05 | -0.63% |
BlackRock Commodity Strategies Inv C | |||
FADAX | 23.91 | -0.26 | -1.08% |
Fidelity Advisor Dividend Growth A |